Last reviewed · How we verify

Silver Colloid

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · FDA-approved active Small molecule

Silver colloid exerts antimicrobial and anti-inflammatory effects through the release of silver ions that disrupt bacterial cell membranes and reduce inflammatory mediators.

Silver colloid exerts antimicrobial and anti-inflammatory effects through the release of silver ions that disrupt bacterial cell membranes and reduce inflammatory mediators. Used for Wound care and infection prevention, Topical antimicrobial applications.

At a glance

Generic nameSilver Colloid
Also known asSilver Hydrosyl by Sovereign Silver
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Drug classAntimicrobial agent
ModalitySmall molecule
Therapeutic areaWound care / Infectious disease
PhaseFDA-approved

Mechanism of action

Silver colloid consists of silver particles suspended in a liquid medium. The silver ions released from these particles have broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses by interfering with cellular respiration and DNA replication. Additionally, silver colloid exhibits anti-inflammatory properties that may promote wound healing and tissue repair.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: